Toby P. Thomas

501 total citations
7 papers, 217 citations indexed

About

Toby P. Thomas is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Toby P. Thomas has authored 7 papers receiving a total of 217 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 3 papers in Molecular Biology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Toby P. Thomas's work include Cardiac Fibrosis and Remodeling (4 papers), Cardiac Ischemia and Reperfusion (2 papers) and Viral Infections and Immunology Research (1 paper). Toby P. Thomas is often cited by papers focused on Cardiac Fibrosis and Remodeling (4 papers), Cardiac Ischemia and Reperfusion (2 papers) and Viral Infections and Immunology Research (1 paper). Toby P. Thomas collaborates with scholars based in United States, Netherlands and Brazil. Toby P. Thomas's co-authors include Laurel A. Grisanti, Miles A. Tanner, Charles A. Maitz, Douglas G. Tilley, Walter J. Koch, Erhe Gao, Claudio de Lucia, Rhonda L. Carter, Jeffrey Benovic and Daohai Yu and has published in prestigious journals such as International Journal of Molecular Sciences, Cardiovascular Research and Theranostics.

In The Last Decade

Toby P. Thomas

7 papers receiving 214 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Toby P. Thomas United States 7 120 107 39 21 21 7 217
Yingguang Shan China 9 121 1.0× 92 0.9× 75 1.9× 12 0.6× 11 0.5× 23 246
Stanislav Keranov Germany 8 178 1.5× 116 1.1× 28 0.7× 24 1.1× 10 0.5× 19 268
Datun Qi China 10 147 1.2× 94 0.9× 43 1.1× 17 0.8× 13 0.6× 34 277
Anikó Görbe Hungary 10 72 0.6× 161 1.5× 49 1.3× 38 1.8× 19 0.9× 21 259
Mónica Flores‐Muñoz Mexico 10 195 1.6× 121 1.1× 23 0.6× 13 0.6× 18 0.9× 21 372
Denielli da Silva Gonçalves Bós Netherlands 10 228 1.9× 59 0.6× 52 1.3× 10 0.5× 15 0.7× 22 363
Sarah Pedretti South Africa 10 86 0.7× 121 1.1× 44 1.1× 67 3.2× 16 0.8× 23 312
Jin Ma China 11 186 1.6× 82 0.8× 14 0.4× 22 1.0× 9 0.4× 22 291
Sara A. Wennersten United States 9 129 1.1× 196 1.8× 34 0.9× 21 1.0× 12 0.6× 12 380
Shenglan Guo China 9 84 0.7× 131 1.2× 30 0.8× 17 0.8× 8 0.4× 15 342

Countries citing papers authored by Toby P. Thomas

Since Specialization
Citations

This map shows the geographic impact of Toby P. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toby P. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toby P. Thomas more than expected).

Fields of papers citing papers by Toby P. Thomas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toby P. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toby P. Thomas. The network helps show where Toby P. Thomas may publish in the future.

Co-authorship network of co-authors of Toby P. Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Toby P. Thomas. A scholar is included among the top collaborators of Toby P. Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toby P. Thomas. Toby P. Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Guo, Shuchi, Rhonda L. Carter, Toby P. Thomas, et al.. (2021). Epidermal growth factor receptor-dependent maintenance of cardiac contractility. Cardiovascular Research. 118(5). 1276–1288. 14 indexed citations
2.
Thomas, Toby P. & Laurel A. Grisanti. (2020). The Dynamic Interplay Between Cardiac Inflammation and Fibrosis. Frontiers in Physiology. 11. 529075–529075. 91 indexed citations
3.
Tanner, Miles A., Toby P. Thomas, Charles A. Maitz, & Laurel A. Grisanti. (2020). β2-Adrenergic Receptors Increase Cardiac Fibroblast Proliferation Through the Gαs/ERK1/2-Dependent Secretion of Interleukin-6. International Journal of Molecular Sciences. 21(22). 8507–8507. 27 indexed citations
4.
Grisanti, Laurel A., Claudio de Lucia, Toby P. Thomas, et al.. (2019). Prior beta blocker treatment decreases leukocyte responsiveness to injury. JCI Insight. 4(9). 25 indexed citations
5.
Tanner, Miles A., Toby P. Thomas, & Laurel A. Grisanti. (2019). Death receptor 5 contributes to cardiomyocyte hypertrophy through epidermal growth factor receptor transactivation. Journal of Molecular and Cellular Cardiology. 136. 1–14. 18 indexed citations
6.
Grisanti, Laurel A., Toby P. Thomas, Rhonda L. Carter, et al.. (2018). Pepducin-mediated cardioprotection via β-arrestin-biased β2-adrenergic receptor-specific signaling. Theranostics. 8(17). 4664–4678. 36 indexed citations
7.
Thomas, Toby P., et al.. (2014). A retrospective evaluation of fondaparinux for confirmed or suspected heparin-induced thrombocytopenia in left-ventricular-assist device patients. Journal of Cardiothoracic Surgery. 9(1). 55–55. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026